|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/506 | |
| A61K 31/713 | |||
| A61K 31/00 | |||
| A61K 45/06 | |||
| A61K 39/395 | |||
| A61P 31/00 | |||
| A61P 35/00 | |||
| A61P 37/04 |
| (11) | Patento numeris | 3285809 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16719655.9 |
| Europos patento paraiškos padavimo data | 2016-04-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-02-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-09-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/027870 |
| Data | 2016-04-15 |
| (87) | Numeris | WO 2016/172010 |
| Data | 2016-10-27 |
| (30) | Numeris | Data | Šalis |
| 201562150140 P | 2015-04-20 | US | |
| 201562260917 P | 2015-11-30 | US |
| (72) |
WEBSTER, Kevin, R., US
GOEL, Vikas, US
|
| (73) |
eFFECTOR Therapeutics, Inc.,
11180 Roselle Street, San Diego, California 92121,
US
|
| (54) | INHIBITORS OF IMMUNE CHECKPOINT MODULATORS FOR USE IN TREATING CANCER AND INFECTIONS |
| INHIBITORS OF IMMUNE CHECKPOINT MODULATORS FOR USE IN TREATING CANCER AND INFECTIONS |